Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fully Automated Glycemic Control With Ultrarapid Insulin in a Bihormonal Closed Loop System in Patients With Type 1 Diabetes

NCT05508061 is registered in ClinicalTrials.gov with Inreda Diabetic B.V. as lead sponsor.

NCT NCT05508061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05508061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fully Automated Glycemic Control With Ultrarapid Insulin in a Bihormonal Closed Loop System in Patients With Type 1 Diabetes
Lead sponsor
Inreda Diabetic B.V.
Phase
Not applicable
Overall status
Completed
Start date
October 19, 2022
Completion date
March 16, 2023
Enrollment
12 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes